Genesis Healthcare, Inc.
GENN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | -0.00 | 0.02 |
| FCF Yield | -239.09% | 41.40% | -192.12% | 38.73% |
| EV / EBITDA | 17.71 | 14.26 | 66.26 | 58.17 |
| Quality | ||||
| ROIC | -0.63% | 0.56% | -2.67% | -1.84% |
| Gross Margin | 2.77% | 6.81% | -3.43% | 43.02% |
| Cash Conversion Ratio | -0.88 | 0.32 | 1.51 | -2.06 |
| Growth | ||||
| Revenue 3-Year CAGR | -9.70% | -8.84% | -8.44% | -7.76% |
| Free Cash Flow Growth | -468.78% | 125.41% | -394.67% | 130.26% |
| Safety | ||||
| Net Debt / EBITDA | 17.54 | 14.07 | 65.64 | 57.31 |
| Interest Coverage | -0.48 | 0.41 | -2.26 | -2.03 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 23.72 | 17.85 | 23.38 | 5.49 |